Market Trends of Extracorporeal Shock Wave Lithotripsy Industry
The Kidney Stones Segment is Projected to Grow Significantly During the Forecast Period
Several risk factors contribute to the prevalence of kidney stones, such as obesity, metabolic disorders, intestinal injuries, certain medications, and diabetes.
According to the International Federation of Diabetics (IFD) Report 2022, the number of people with diabetes is expected to rise to 643 million by 2030 and 783 million by 2045. Moreover, the incidence of Type 2 diabetes is rising rapidly in low- and middle-income countries, affecting 79% of adults in these regions. For people with diabetes, kidney stones can be especially troublesome, as the sugar in their urine creates a breeding ground for bacteria. As a result, the increasing prevalence of diabetes and kidney stones is expected to boost the demand for kidney stone treatments over the forecast period.
One of the most common and effective treatments for kidney stones is extracorporeal shock wave lithotripsy (ESWL). This procedure involves shattering the kidney stone into smaller fragments that can quickly pass through the urinary tract and exit the body. For instance, according to the study published in the African Journal of Urology in January 2024, ESWL monotherapy is a safe and effective treatment for vesical calculi, providing patients with minimal discomfort, particularly when performed in a supine position without the routine use of a per urethral catheter.
According to the above study, ESWL should receive greater consideration from urologists managing vesical calculi. The study highlighted a notable success rate for ESWL at 93.1% after a single session, increasing to 100% after two sessions. Therefore, the high success rate of ESWL in managing kidney stones is anticipated to increase the adoption of this technique, thereby boosting the segment’s growth.
The kidney stones segment is poised for significant growth over the forecast period due to the rising incidence of kidney stones worldwide and increasing risk factors such as diabetes, obesity, and metabolic disorders. Additionally, the increased success of the ESWL technique in the management of kidney stones is expected to drive market growth.
North America is Anticipated to Hold a Significant Market Share During the Forecast Period
North America is expected to hold a significant market share in the ESWL market over the forecast period, owing to many obese and diabetic patients prone to stone formation.
According to the research study published in the Journal of Americal Urological Association in January 2024, among US adults aged 20 years and older, 9.9% (23.7 million) of individuals reported a history of kidney stones during their lifetime, and 1.8% (4.4 million) had passed a kidney stone in the past 12 months. Therefore, the high prevalence and incidence of kidney stones are anticipated to increase the adoption of non-invasive treatments such as ESLW for kidney stones, thereby propelling market growth.
Furthermore, according to the research article published by Cleaveland Clinic in April 2024, ESWL stands out as a crucial, minimally invasive alternative to surgery for large stones and offers a promising solution for complex cases. Such research studies indicate the importance of ESWL as it enhances the treatment portfolio of hospitals and expands the treatment options available to patients, thereby boosting market growth.
Thus, owing to the above-mentioned factors, such as the high prevalence of kidney stones and the significance of ESWL in treating kidney stones, the market is expected to grow over the forecast period.
